Skip to main content
Clinical Trials/IRCT2015082022734N1
IRCT2015082022734N1
Completed
Phase 2

Clinical trial comparison of sedation and hemodynamic effects between propofol and etomidate in urological patients

Dr Hamideh Yousefnezhad0 sites177 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
urological disease.
Sponsor
Dr Hamideh Yousefnezhad
Enrollment
177
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Hamideh Yousefnezhad

Eligibility Criteria

Inclusion Criteria

  • inclusion criteria:
  • patients with ambulatory elective urological surgery; age more than 50; ASA class I , II
  • exclusion criteria:
  • history of adrenal insufficiency; history of vital sign instability; history of allergy to the Etomidate or Propofol

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials